Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX: AXPH)

AXPH Revenue

Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 486.48M EGP in the quarter ending September 30, 2023, with 68.55% growth. This brings the company's revenue in the last twelve months to 1.80B, up 56.02% year-over-year. In the fiscal year ending June 30, 2023, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 1.48B with 34.94% growth.

• Revenue (ttm): 1.80B
• Revenue Growth: +56.02%
• P/S Ratio: 0.64
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	1.48B	384.31M	34.94%
Jun 30, 2022	1.10B	-4.24M	-0.38%
Jun 30, 2021	1.10B	79.44M	7.75%
Jun 30, 2020	1.02B	195.78M	23.61%
Jun 30, 2019	829.04M	125.35M	17.81%